Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Fluxion Launches High Throughput Quattro Array for BioFlux™

Published: Friday, October 18, 2013
Last Updated: Friday, October 18, 2013
Bookmark and Share
Quattro increases throughput 4X, enables HCS endpoint readout.

Fluxion Biosciences has announced that it has launched its BioFlux Quattro High Throughput Array System for physiologically relevant live cell analysis. The system is now commercially available and shipping to customers.

The Quattro Array system is sold as a separate component and can expand the capabilities of any existing BioFlux 200 or BioFlux 1000/1000z system. The Quattro Array runs up to 4 BioFlux plates at the same time.

Plates can be read by a microscope or High Content Screening system as a time-point or end-point assay. The increased throughput is especially valuable for lead optimization applications where the ability to closely simulate in vivo conditions is critical to identifying the best candidates for clinical development.

Introduced 5 years ago, the BioFlux system provides the ability to emulate physiological flow and shear forces in an in vitro model, while retaining the industry standard well plate format.

The system allows the execution of a multitude of assays requiring precise manipulation of the cellular micro-environment, including control of liquid composition, oxygen content, temperature, and shear.

Providing a much better approximation of in vivo conditions than traditional static well plate assays, BioFlux is becoming a standard in drug development and is used in many leading pharmaceutical companies such as Sanofi-Aventis, Actelion, Pfizer, Amgen, BMS, Merck, Bayer, Genentech, and many others.

“With the introduction of the BioFlux Quattro Array, we provide new and existing customers the ability to expand the throughput of their assays where physiologically-relevant conditions are required” said Jeff Jensen, CEO of Fluxion Biosciences.

Jensen continued, “Anti-platelet, anti-microbial, cancer, and anti-inflammatory drugs (to name a few) are examples of applications where drug response is affected by the environment around the cells. In these and many other drug applications, drug activity modulates, or is affected by, cellular responses caused by mechanical stress, dissolved gas concentration, or drug delivery profiles. With its unique capability to mimic conditions in the body, now at even higher throughput, the BioFlux system with the Quattro Array is a significant advance for drug development.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Fluxion Biosciences, UT Health Collaborate
Company has announced collaboration with UT Health to develop novel liquid biopsy approaches to improve the ability to diagnose, monitor, and treat cancer patients.
Saturday, April 30, 2016
Stanford University Study Shows Early Detection of CTCs in NSCLC Patients
IsoFlux System demonstrates high sensitivity CTC recovery in challenging patient group.
Tuesday, November 26, 2013
Fluxion Biosciences to Distribute Millipore PrecisION® Ion Channel Cell Lines
Combination with IonFlux™ automated patch clamp system creates a validated, affordable solution for ion channel profiling and screening.
Thursday, December 22, 2011
Research Team from Fred Hutchinson Cancer Center Wins 2010 BioFlux Innovation Award
Group will use BioFlux System for advanced screening applications applicable to women’s reproductive health.
Saturday, September 18, 2010
Ohio State University Researchers Adopt IonFlux 16 Automated Patch Clamp System
First of kind high throughput instrument for research applications enables ion channel studies.
Monday, August 16, 2010
Fluxion Receives $1.2M NIH Grant for the Development of Drug Discovery Platform
Grant funds development of multiplexed single-cell electroporation system for highly controlled siRNA delivery.
Monday, May 21, 2007
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Modified Yeast Shows Plant Response to Key Hormone
Researchers have developed a toolkit based on modified yeast to determine plant responses to auxin.
Adipose Tissue Secretes Factors That Activate Metabolism
Study finds brown adipose tissue secretes signalling factors that activates metabolism of fat and carbohydrates.
Antibiotic Resistant Bacteria In America's Water System
Antibiotic resistant bacteria live inside drinking water distribution systems blamed for rising healthcare costs.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Ancient Eggshell Protein Breaks Through DNA Time Barrier
Fossil proteins from a 3.8million year-old eggshell have been identifed, suggests proteins could give insight into evolutionary tree.
Monkeys Protected by Zika DNA Vaccine
Experimental Zika virus DNA vaccines successfully protected monkeys against Zika infection.
Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!